Jennifer Champoux

Vermogen: 809 999 $ op 31-05-2024

Health Technology

Consumer Services

Actieve functies van Jennifer Champoux

Bedrijven	Functie	Begin	Einde
MONTE ROSA THERAPEUTICS, INC.	Operationeel Directeur	01-03-2021	-
MONTE ROSA THERAPEUTICS, INC.	Human Resources Officer	01-03-2021	28-05-2024

Bedrijven	Functie	Begin	Einde
H3 Biomedicine, Inc. H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa.	Corporate Officer/Principal	-	-

Indiana University

Graduate Degree

Internationaal

Verenigde Staten

Operationeel

Chief Operating Officer	1
Human Resources Officer	1
Corporate Officer/Principal	1

Sectoraal

Health Technology	3
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
MONTE ROSA THERAPEUTICS, INC.	Health Technology

Bedrijven in privébezit	1
H3 Biomedicine, Inc. H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa.	Health Technology

Bedrijven in privébezit

Health Technology